论文部分内容阅读
目的探讨氨茶碱联合参麦注射液治疗慢性阻塞性肺疾病的临床应用价。方法选取本院呼吸内科的慢性阻塞性肺疾病(COPD)患者80例,将其分为治疗组和对照组,每组各40例。对照组给予氨茶碱治疗,治疗组在对照组治疗基础上给予参麦注射液治疗。观察对比两组临床疗效、肺功能指标和动脉血压分析的变化。结果治疗组总有效率为92.5%,对照组总有效率为82.5%,两组总有效率比较,差异有统计学意义(P<0.05)。治疗后治疗组肺功能和动脉血气分析情况优于对照组,差异有统计学意义(均P<0.05)。结论氨茶碱联合参麦注射液治疗慢性阻塞性肺疾病较单纯的西医治疗效果好,值得临床推广应用。
Objective To investigate the clinical value of aminophylline combined with Shenmai injection in the treatment of chronic obstructive pulmonary disease. Methods Eighty patients with chronic obstructive pulmonary disease (COPD) in our department were divided into treatment group and control group, 40 cases in each group. The control group was treated with aminophylline, and the treatment group was treated with Shenmai injection on the basis of the control group. The changes of clinical curative effect, pulmonary function index and arterial blood pressure analysis were observed and compared. Results The total effective rate was 92.5% in the treatment group and 82.5% in the control group. The total effective rate in the two groups was statistically significant (P <0.05). After treatment, the pulmonary function and arterial blood gas analysis in the treatment group was better than that in the control group, with significant difference (all P <0.05). Conclusion The combination of aminophylline and Shenmai injection in the treatment of chronic obstructive pulmonary disease is more effective than simple Western medicine and is worthy of clinical application.